Evidence map›Paper›PMID 24284512›Full record

ArticleKidney international2014

A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis.

Jianling Tao, Christina Polumbo, Kimberly Reidy, Mariya Sweetwyne, Katalin Susztak

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  3. Clonal Tracing of Heart Regeneration.Journal of cardiovascular development and disease · 2022
    Review
  4. Review
  5. Novel Microscopic Techniques for Podocyte Research.Frontiers in endocrinology · 2018
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Jianling Tao1] Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA [2] Division of Nephrology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Christina PolumboAnalytical Imaging Facility, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
Kimberly ReidyDivision of Nephrology, Department of Pediatrics, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
Mariya SweetwyneRenal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Katalin SusztakRenal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
University of Pennsylvania · USAlbert Einstein College of Medicine · USChinese Academy of Medical Sciences & Peking Union Medical College · CNYeshiva University · US

Funding

Role of the Notch Pathway in Kidney InjuryR01DK076077 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2007 to 2026
$8.0M
Role of Par1 Polarity Proteins in Podocyte Development and Glomerular DiseaseK08DK091507 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI REIDY, KIMBERLY JEAN · 2011 to 2015
$667k
NIDDK NIH HHS K08 DK091507NIDDK NIH HHS K08 DK091507-03NIDDK NIH HHS R01 DK076077
6 · The paper itself

Abstract

In contrast to most glomerular diseases, the injury pattern in focal segmental glomerulosclerosis (FSGS) is highly heterogeneous, even though podocytes are genetically identical and exposed to the same environmental factors. To understand changes in individual podocytes, we generated and analyzed a stochastic multicolor Cre-reporter, encoding four fluorescent proteins. In these animals, podocytes were randomly labeled allowing individual cells and their foot processes to be distinguished. In healthy animals, podocyte size and structure showed little cell to cell variability. In the doxorubicin-induced FSGS model, fluorescent-labeled glomerular podocyte numbers decreased and fluorescent cells could be recovered from the urine. The size of the remaining podocytes showed a high degree of heterogeneity, some cells remained small, while others enlarged. Both enlarged and non-enlarged podocytes showed alterations in their foot process morphology. Thus, by the virtue of a multicolor cre-reporter, individual podocytes could be viewed in real time at a cellular resolution indicating a heterogeneous podocyte injury response during the pathogenesis of FSGS.

Indexed as

Disease Models, AnimalGenes, ReporterAnimalsCell ShapeDoxorubicinGlomerulosclerosis, Focal SegmentalLuminescent ProteinsMaleMicePodocytesDoxorubicinLuminescent Proteins

Identifiers

PMID24284512
PMCPMC3987991
OpenAlexW2047251187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.